T-CELL RESPONSES TO MYELIN PROTEINS IN GUILLAIN-BARRE-SYNDROME

被引:69
|
作者
KHALILISHIRAZI, A
HUGHES, RAC
BROSTOFF, SW
LININGTON, C
GREGSON, N
机构
[1] MED UNIV S CAROLINA,DEPT NEUROL,CHARLESTON,SC 29425
[2] MAX PLANCK INST PSYCHIAT,NEUROIMMUNOL ABT,W-8000 MUNICH 40,GERMANY
[3] UNITED MED & DENT SCH,DIV ANAT & CELL BIOL,LONDON SE1 9RT,ENGLAND
关键词
GUILLAIN-BARRE SYNDROME; P0; P2; PEPTIDE; T-CELL; MOLECULAR MIMICRY;
D O I
10.1016/0022-510X(92)90069-W
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We have investigated the hypothesis that the pathogenesis of Guillain-Barre syndrome (GBS) involves an autoimmune T cell response to P0 and P2 proteins of peripheral nerve myelin. The proliferative responses of blood mononuclear cells (MNC) to myelin proteins and synthetic peptides derived from them were determined in patients with GBS and chronic idiopathic demyelinating polyradiculoneuropathy (CIDP), normal controls (NC) and patients with other neuropathies (ONP). Twelve out of 19 GBS patients responded to P0 or P2, 6 to P0 and its peptides only, 3 to P2 and its peptides only, and 3 to both P0 and P2 antigens. Responses to at least one of the antigens were also found in 6/13 of CIDP patients, but in only 4/17 NC and 2/6 ONP. Immune responses in GBS are heterogeneous. The early T cell responses to P0 protein, described here for the first time, may be important in the pathogenesis of some cases.
引用
收藏
页码:200 / 203
页数:4
相关论文
共 50 条
  • [21] GUILLAIN-BARRE-SYNDROME FOLLOWING STREPTOKINASE THERAPY
    KAISER, R
    KAUFMANN, R
    CZYGAN, M
    LANG, H
    LUCKING, CH
    CLINICAL INVESTIGATOR, 1993, 71 (10): : 795 - 801
  • [22] PLASMA-EXCHANGE AND GUILLAIN-BARRE-SYNDROME
    RAPHAEL, JC
    ELKHARRAT, D
    CHEVRET, S
    VERCKEN, JB
    CHASTANG, C
    GAJDOS, P
    ANNALES DE MEDECINE INTERNE, 1990, 141 (07): : 593 - 596
  • [23] GUILLAIN-BARRE-SYNDROME FOLLOWING MENINGOCOCCAL MENINGITIS
    PURI, V
    KHALIL, A
    SURI, V
    POSTGRADUATE MEDICAL JOURNAL, 1995, 71 (831) : 42 - 43
  • [24] GUILLAIN-BARRE-SYNDROME FOLLOWING SEVERE EXERTION
    ADOGU, AA
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1991, 84 (02) : 116 - 117
  • [25] GANGLIOSIDES AND BACTERIAL TOXINS IN GUILLAIN-BARRE-SYNDROME
    WILLISON, HJ
    KENNEDY, PGE
    JOURNAL OF NEUROIMMUNOLOGY, 1993, 46 (1-2) : 105 - 112
  • [26] ELECTROPHYSIOLOGICAL INVESTIGATIONS IN ACUTE GUILLAIN-BARRE-SYNDROME
    MAMOLI, B
    ACKERL, M
    WIENER KLINISCHE WOCHENSCHRIFT, 1991, 103 : 8 - 12
  • [27] TREATMENT STRATEGIES FOR PATIENTS WITH THE GUILLAIN-BARRE-SYNDROME
    BLECK, TP
    CRITICAL CARE MEDICINE, 1993, 21 (05) : 641 - 643
  • [28] THE GUILLAIN-BARRE-SYNDROME - NO LONGER A SIMPLE CONCEPT
    THOMAS, PK
    JOURNAL OF NEUROLOGY, 1992, 239 (07) : 361 - 362
  • [29] GUILLAIN-BARRE-SYNDROME IN PREGNANCY - REFLECTIONS ON IMMUNOPATHOGENESIS
    ROLFS, A
    BOLIK, A
    ACTA NEUROLOGICA SCANDINAVICA, 1994, 89 (05): : 400 - 402
  • [30] EVOKED-POTENTIALS IN GUILLAIN-BARRE-SYNDROME
    TOPCU, M
    ERGIN, M
    NURLU, G
    RENDA, Y
    KANRA, G
    SECMEER, G
    TURKISH JOURNAL OF PEDIATRICS, 1993, 35 (02) : 79 - 85